Bio

Global-minded , fast-paced , commercial pharma growth leader.


CEO experience with over 200 people spread in more than 20 countries in Europe, Asia as well as Americas and responsible for 3 Digit Mio USD EBITDA contributing P&L.

Successfully managed 2 independent turnarounds for loss making or start-up businesses.

Extensive market experience in highly regulated as well as less regulated markets in more than 100 countries worldwide with a track record of more than 1000 (Deal Value >$20bn ) License, Supply, Acquisition, Co-Development, Distribution, Sales and Marketing Agreements with an excellent network in the pharmaceutical industry.

Recognitions
*X-Factor: 2018, Alvogen
*The Performance of the Year: 2019, Adalvo
*X-Factor: 2019, Alvotech
*The Performance of the Year: 2020, Adalvo
*The Manager of the Year: 2020
*Leader of the Year: 2021 , Global Generics & Biosimilars Awards